Discrepancies in liver disease labeling in the package inserts of commonly prescribed medications.

@article{Bjornsson2015DiscrepanciesIL,
  title={Discrepancies in liver disease labeling in the package inserts of commonly prescribed medications.},
  author={Einar Stefan Bjornsson and Elin I Jacobsen and Rannveig Alma Einarsd{\'o}ttir and Naga Chalasani},
  journal={Gastroenterology},
  year={2015},
  volume={148 2},
  pages={269-73}
}
ach drug approved by regulaEtory authorities for human use is accompanied by a package insert, also known as “prescribing information” in the United States and the “patient information” leaflet in Europe, which provides its salient features in a structured format. Although pharmaceutical companies submit the summary of product characteristics, the Food and Drug Administration in the United States and the European Medicines Agency in Europe are responsible for reviewing and publishing the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
5 Citations
8 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Antiinflammatory drugs and variceal bleeding: a case-control study

  • V de Ledinghen, D Heresbach, O Fourdan
  • Gut
  • 1999

Similar Papers

Loading similar papers…